Philippe Chambon

Director/Board Member at

BioRelix, Inc.

67 year

69 connections

Health Technology

Technology Services

Finance

Profile

Philippe O.
Chambon was the founder of New Leaf Venture Partners LLC, serving as Managing Director since 2005 until 2018.
Current jobs include Director at BioRelix, Inc. since 2009, Director at Qpid Health, Inc. since 2014, Director at Phylos, Inc., Director at FeetMe SAS, Director at Stilla Technologies SA since 2018, Director at Novadiscovery SAS, and Venture Partner at LBO France Gestion SAS since 2018.
Former jobs include Chairman at NxStage Medical, Inc. from 1998 to 2013, Director at Transcend Therapeutics, Inc., Director at Nuvelo, Inc., Director at Pharsight Corp.
in 2007, Director at Kalypsys, Inc., Director at Auxilium Pharmaceuticals LLC from 2003 to 2011, Independent Director at Epocrates LLC from 2011 to 2013, Director at Aureon Biosciences, Inc., Director at Truveris, Inc., Director at Principia Biopharma, Inc., Director at Spotfire, Inc., Director at VaxInnate Corp., Director at Artisan Pharma, Inc., Executive Director-New Product Management at Sandoz Pharmaceuticals Corp.
in 1993, Independent Non-Executive Director at Pharnext SA in 2018, Director at Karos Pharmaceuticals, Inc., Director at Treato Ltd., Director at Tribun Health SAS, General Partner at Sprout Group from 1995 to 2004, and Manager-Healthcare Practice at The Boston Consulting Group, Inc. from 1993 to 1995.
Education includes an MBA from The Trustees of Columbia University in The City of New York and a doctorate from Université Paris 1 Panthéon-Sorbonne.

Philippe Chambon active positions

Companies	Position	Start
BioRelix, Inc. BioRelix, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of antibiotics	Director/Board Member	16/04/2009
Qpid Health, Inc. Qpid Health, Inc. Packaged SoftwareTechnology Services Provides health record acceleration software and intelligence solutions	Director/Board Member	06/05/2014
Phylos, Inc. Phylos, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research and manufacturing services	Director/Board Member	-
LBO France Gestion SAS LBO France Gestion SAS Investment ManagersFinance LBO France is an active manager which invests in small- to medium-sized French or French-managed companies across a variety of sectors. The firm takes majority or controlling minority positions in companies valued between 10 million to 2.5 billion euros across manufacturing and services sectors, seeking to invest in profitable, market-leading businesses with growth potential. LBO France always takes a seat on the Supervisory Board of their investee companies, supporting management with strategic decisions and not interfering with day-to-day management. The firm invests in a limited number of companies, generally holding an investment for three to seven years, seeking to realize investments by finding a trade purchaser or arranging a secondary LBO or an IPO. For small-cap investments, LBO France focuses exclusively on unquoted companies with enterprise values of 10 to 50 million euros which have predictable revenue, profit and cash flows, excellent potential for growth or consolidation and a solid business plan offering good prospects for increasing valuation. For medium-sized firms with an enterprise value of 0.1 to 2.5 billion euros, the firm employs either a continuity or transformation strategy. Their continuity strategy utilizes leverage to acquire a majority stake in companies with predictable sales, profits and cash flow, a competitive cost structure or one that may be rapidly improved, a capable existing or potential management team and a strong market position and possible market leadership. Investee companies may be family-owned companies or subsidiaries or divisions of major groups. The firm's transformation strategy involves taking a majority or a minority position in companies with distinct and disposable business activities, under-utilized assets, substantial market share and a competitive advantage. They focus each company on their fastest-growing businesses and markets and sell their other businesses. They seek to increase operating margins by reducing costs, freeing up working capital and developing new business and set up management teams using performance-based remuneration to motivate them. LBO France's real estate team specializes in the French property sector, investing in all asset types and market segments including property companies, properties that generate capital gains (held from three to five years) and income properties (held for over five years). The firm's real estate team targets investments with asset values greater than 30 million euros.	Private Equity Investor	01/02/2018
Stilla Technologies SA Stilla Technologies SA Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology and operates software application	Director/Board Member	25/11/2018
Novadiscovery SAS Novadiscovery SAS Information Technology ServicesTechnology Services Operates as a health technology company	Director/Board Member	-
FeetMe SAS FeetMe SAS Electronic Equipment/InstrumentsElectronic Technology Develops smart connected insoles that can measure data and transfer wirelessly to a device	Director/Board Member	-

All active positions of Philippe Chambon

Former positions of Philippe Chambon

Companies	Position	End
New Leaf Venture Partners LLC New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements.	Founder	31/12/2018
PHARNEXT SCA	Director/Board Member	17/09/2018
░░░░░░░ ░░░░░░░░ ░░░░	░░░░░░░░	░░░░░░░░░░
░░░░░░░░░ ░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░

See the detail of Philippe Chambon's experience

Training of Philippe Chambon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Philippe Chambon's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	30
Transcend Therapeutics, Inc. Transcend Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products	Health Technology
Nuvelo, Inc. Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies	Health Technology
Pharsight Corp. Pharsight Corp. Packaged SoftwareTechnology Services Develops computer-assisted trial design software	Technology Services
Kalypsys, Inc. Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases	Health Technology
Auxilium Pharmaceuticals LLC Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products	Health Technology
Epocrates LLC Epocrates LLC Medical SpecialtiesHealth Technology Provides clinical tools and solutions	Health Technology
Aureon Biosciences, Inc. Aureon Biosciences, Inc. BiotechnologyHealth Technology Develops predictive tests for cancer recurrence and provides contract research services	Health Technology
BioRelix, Inc. BioRelix, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of antibiotics	Health Technology
Truveris, Inc. Truveris, Inc. Medical/Nursing ServicesHealth Services Provides health information technology services	Health Services
Principia Biopharma, Inc. Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company	Health Technology
Qpid Health, Inc. Qpid Health, Inc. Packaged SoftwareTechnology Services Provides health record acceleration software and intelligence solutions	Technology Services
Sprout Group Sprout Group Investment ManagersFinance Sprout invest in companies located in North America. The firm focuses communications, software, services & e-commerce and healthcare technology sectors.	Finance
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
LBO France Gestion SAS LBO France Gestion SAS Investment ManagersFinance LBO France is an active manager which invests in small- to medium-sized French or French-managed companies across a variety of sectors. The firm takes majority or controlling minority positions in companies valued between 10 million to 2.5 billion euros across manufacturing and services sectors, seeking to invest in profitable, market-leading businesses with growth potential. LBO France always takes a seat on the Supervisory Board of their investee companies, supporting management with strategic decisions and not interfering with day-to-day management. The firm invests in a limited number of companies, generally holding an investment for three to seven years, seeking to realize investments by finding a trade purchaser or arranging a secondary LBO or an IPO. For small-cap investments, LBO France focuses exclusively on unquoted companies with enterprise values of 10 to 50 million euros which have predictable revenue, profit and cash flows, excellent potential for growth or consolidation and a solid business plan offering good prospects for increasing valuation. For medium-sized firms with an enterprise value of 0.1 to 2.5 billion euros, the firm employs either a continuity or transformation strategy. Their continuity strategy utilizes leverage to acquire a majority stake in companies with predictable sales, profits and cash flow, a competitive cost structure or one that may be rapidly improved, a capable existing or potential management team and a strong market position and possible market leadership. Investee companies may be family-owned companies or subsidiaries or divisions of major groups. The firm's transformation strategy involves taking a majority or a minority position in companies with distinct and disposable business activities, under-utilized assets, substantial market share and a competitive advantage. They focus each company on their fastest-growing businesses and markets and sell their other businesses. They seek to increase operating margins by reducing costs, freeing up working capital and developing new business and set up management teams using performance-based remuneration to motivate them. LBO France's real estate team specializes in the French property sector, investing in all asset types and market segments including property companies, properties that generate capital gains (held from three to five years) and income properties (held for over five years). The firm's real estate team targets investments with asset values greater than 30 million euros.	Finance
Phylos, Inc. Phylos, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research and manufacturing services	Commercial Services
The Boston Consulting Group, Inc. The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services	Commercial Services
NxStage Medical, Inc. NxStage Medical, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets products for the treatment of kidney failure and related diseases	Health Technology
Spotfire, Inc. Spotfire, Inc. Packaged SoftwareTechnology Services Develops enterprise data analytics, business intelligence, data visualization and AI-powered analytics software	Technology Services
Université Paris 1 Panthéon-Sorbonne Université Paris 1 Panthéon-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
New Leaf Venture Partners LLC New Leaf Venture Partners LLC Investment ManagersFinance New Leaf Ventures invests in public and private healthcare technology companies located in the US. The firm participates in early and later-stage capital requirements.	Finance
VaxInnate Corp. VaxInnate Corp. Pharmaceuticals: MajorHealth Technology Develops novel, proprietary vaccines for infectious diseases	Health Technology
Artisan Pharma, Inc. Artisan Pharma, Inc. Hospital/Nursing ManagementHealth Services Provides critical-care and hospital-based therapeutics to patients	Health Services
Sandoz Pharmaceuticals Corp.
Pharnext SA Pharnext SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for patients to treat neurodegenerative diseases	Health Technology
Karos Pharmaceuticals, Inc. Karos Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services	Health Technology
Treato Ltd. Treato Ltd. Packaged SoftwareTechnology Services Provides social health patient intelligence solutions	Technology Services
FeetMe SAS FeetMe SAS Electronic Equipment/InstrumentsElectronic Technology Develops smart connected insoles that can measure data and transfer wirelessly to a device	Electronic Technology
Stilla Technologies SA Stilla Technologies SA Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing biotechnology and operates software application	Commercial Services
Tribun Healthcare SAS Tribun Healthcare SAS Packaged SoftwareTechnology Services Develops software for digital pathology	Technology Services
Novadiscovery SAS Novadiscovery SAS Information Technology ServicesTechnology Services Operates as a health technology company	Technology Services